Literature DB >> 10702179

Randomized diet in the neonatal period and growth performance until 7.5-8 y of age in preterm children.

R Morley1, A Lucas.   

Abstract

BACKGROUND: Preterm children are at high risk of poor growth performance. In 2 randomized trials, preterm infants fed preterm formula grew better in the neonatal period than those fed banked donor breast milk or standard term formula.
OBJECTIVE: Our objective was to test the hypothesis that for preterm infants, the neonatal period is a critical one for programming growth performance and that early diet influences long-term growth.
DESIGN: A total of 926 preterm infants were recruited into 2 parallel, randomized trials of neonatal diet. In trial 1, infants were fed either banked donor breast milk or preterm formula whereas in trial 2, infants were fed either standard term formula or preterm formula. Within each trial, the allocated milk was the sole diet for some infants (study A), whereas for others it was a supplement to maternal breast milk, given when not enough expressed breast milk was available (study B). We followed up 781 of 833 survivors (94%) to age 7.5-8 y. Trained assessors obtained anthropometric measurements according to a standard protocol.
RESULTS: Despite significantly better neonatal growth performance in infants fed preterm formula (compared with either banked donor breast milk or standard formula), early diet had no influence on weight, height, head circumference, or skinfold thicknesses at 9 or 18 mo postterm or at age 7.5-8 y.
CONCLUSIONS: These findings suggest that the preterm period is not a critical window for nutritional programming of growth, which contrasts with evidence from these trials showing that early diet influences later neurodevelopment.

Entities:  

Mesh:

Year:  2000        PMID: 10702179     DOI: 10.1093/ajcn/71.3.822

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  17 in total

Review 1.  Early enteral feeding of the preterm infant.

Authors:  A F Williams
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-11       Impact factor: 5.747

Review 2.  Feeding the preterm infant.

Authors:  William McGuire; Ginny Henderson; Peter W Fowlie
Journal:  BMJ       Date:  2004-11-20

3.  Banking for the future: investing in human milk.

Authors:  Anthony F Williams; Camilla C Kingdon; Gillian Weaver
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-05       Impact factor: 5.747

Review 4.  Higher versus lower protein intake in formula-fed low birth weight infants.

Authors:  Tanis R Fenton; Shahirose S Premji; Heidi Al-Wassia; Reg S Sauve
Journal:  Cochrane Database Syst Rev       Date:  2014-04-21

5.  Early growth and childhood obesity: a historical cohort study.

Authors:  S Kinra; J H Baumer; G Davey Smith
Journal:  Arch Dis Child       Date:  2005-08-30       Impact factor: 3.791

6.  Formula versus donor breast milk for feeding preterm or low birth weight infants.

Authors:  Maria Quigley; Nicholas D Embleton; William McGuire
Journal:  Cochrane Database Syst Rev       Date:  2019-07-19

7.  Higher versus lower protein intake in formula-fed low birth weight infants.

Authors:  Tanis R Fenton; Heidi Al-Wassia; Shahirose S Premji; Reg S Sauve
Journal:  Cochrane Database Syst Rev       Date:  2020-06-23

8.  Prevention of postnatal growth restriction by the implementation of an evidence-based premature infant feeding bundle.

Authors:  P D Graziano; K A Tauber; J Cummings; E Graffunder; M J Horgan
Journal:  J Perinatol       Date:  2015-04-16       Impact factor: 2.521

9.  Nutrient-enriched formula versus standard formula for preterm infants.

Authors:  Verena Walsh; Jennifer Valeska Elli Brown; Lisa M Askie; Nicholas D Embleton; William McGuire
Journal:  Cochrane Database Syst Rev       Date:  2019-07-17

Review 10.  Donor breast milk versus infant formula for preterm infants: systematic review and meta-analysis.

Authors:  Catherine A Boyd; Maria A Quigley; Peter Brocklehurst
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-03-23       Impact factor: 5.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.